Rotten Tomato Stocks
No Result
View All Result
  • News
    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

  • NYSE
    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

  • NASDAQ
    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Petco Shares Sink 13% After Issuing FY23 Guidance

    Petco Shares Sink 13% After Issuing FY23 Guidance

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

  • News
    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

  • NYSE
    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

  • NASDAQ
    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Petco Shares Sink 13% After Issuing FY23 Guidance

    Petco Shares Sink 13% After Issuing FY23 Guidance

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

No Result
View All Result
Rotten Tomato Stocks
No Result
View All Result

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Analysts Are Reducing Their Forecasts For This Year

Editorial Staff by Editorial Staff
May 5, 2021
0
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Analysts Are Reducing Their Forecasts For This Year

The latest analyst coverage could presage a bad day for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon. Investors however, have been notably more optimistic about Apellis Pharmaceuticals recently, with the stock price up a worthy 11% to US$50.20 in the past week. With such a sharp increase, it seems brokers may have seen something that is not yet being priced in by the wider market.

After the downgrade, the consensus from Apellis Pharmaceuticals’ 13 analysts is for revenues of US$27m in 2021, which would reflect a painful 89% decline in sales compared to the last year of performance. Losses are supposed to balloon 51% to US$7.07 per share. However, before this estimates update, the consensus had been expecting revenues of US$46m and US$6.43 per share in losses. So there’s been quite a change-up of views after the recent consensus updates, with the analysts making a serious cut to their revenue forecasts while also expecting losses per share to increase.

earnings-and-revenue-growth
earnings-and-revenue-growth

There was no major change to the consensus price target of US$69.73, signalling that the business is performing roughly in line with expectations, despite lower earnings per share forecasts. There’s another way to think about price targets though, and that’s to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Apellis Pharmaceuticals, with the most bullish analyst valuing it at US$130 and the most bearish at US$39.00 per share. We would probably assign less value to the forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. As a result it might not be possible to derive much meaning from the consensus price target, which is after all just an average of this wide range of estimates.

The Bottom Line

The most important thing to note from this downgrade is that the consensus increased its forecast losses this year, suggesting all may not be well at Apellis Pharmaceuticals. The lack of change in the price target is puzzling in light of the downgrade but, with a serious decline expected this year, we wouldn’t be surprised if investors were a bit wary of Apellis Pharmaceuticals.

Related Posts

Cidara Therapeutics Down 3% After Hours Following FDA Approval
NASDAQ

Cidara Therapeutics Down 3% After Hours Following FDA Approval

March 24, 2023
Xerox Holdings Corp. stock falls Thursday, underperforms market
NASDAQ

Xerox Holdings Corp. stock falls Thursday, underperforms market

March 24, 2023
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade
NASDAQ

Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

March 24, 2023
Petco Shares Sink 13% After Issuing FY23 Guidance
NASDAQ

Petco Shares Sink 13% After Issuing FY23 Guidance

March 22, 2023
Load More
Next Post
TESSCO Technologies’ (NASDAQ:TESS) Shareholders Are Down 56% On Their Shares

TESSCO Technologies' (NASDAQ:TESS) Shareholders Are Down 56% On Their Shares

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

POPULAR NEWS

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

April 14, 2021
CN Rail Stock Is So Undervalued That it’s Absurd

CN Rail Stock Is So Undervalued That it’s Absurd

May 2, 2021
US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

June 17, 2021
Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

September 14, 2021
10 Warning Signs That Should Tell You “This Stock is in Trouble”

10 Warning Signs That Should Tell You “This Stock is in Trouble”

November 11, 2019

EDITOR'S PICK

Is JAKKS Pacific (NASDAQ:JAKK) Using Too Much Debt?

Is JAKKS Pacific (NASDAQ:JAKK) Using Too Much Debt?

February 15, 2022
Dow drops 416 points on losses for Nike, Caterpillar shares

Dow drops 416 points on losses for Nike, Caterpillar shares

September 20, 2022
Hayward (NYSE:HAYW) Shares Gap Down on Analyst Downgrade

Hayward (NYSE:HAYW) Shares Gap Down on Analyst Downgrade

October 17, 2022
There’s Some Bad News About a Fourth Stimulus Check

There’s Some Bad News About a Fourth Stimulus Check

June 1, 2021

Stay Updated

Get breaking news delivered straight into your inbox

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Rotten Tomato Stocks cover the companies and markets that are declining, failing or headed for disaster. We help investors spot the down tends and recognize when something smells rotten.

RECENT POSTS

Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

UnitedHealth Group Inc. stock falls Thursday, underperforms market

POPULAR POSTS

Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

Cidara Therapeutics Down 3% After Hours Following FDA Approval

Xerox Holdings Corp. stock falls Thursday, underperforms market

© Copyright 2023 RottenTomatoStocks. All Rights Reserved 

Disclaimer | Privacy Policy

No Result
View All Result
  • HOME
  • NEWS
  • NYSE
  • NASDAQ
  • OTC
  • TSX

© 2021 RottenTomatoStocks.com

error: Content is protected !!
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.